Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-01-02 @ 9:50 PM
Study NCT ID:
NCT02639260
Status:
COMPLETED
Last Update Posted:
2023-02-24
First Post:
2015-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-23
First Submit QC Date:
None
Study First Post Date:
2015-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-22
Last Update Post Date:
2023-02-24
Last Update Post Date Type:
ACTUAL